Cedar Brook Financial Partners’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,000
Closed -$201K 384
2022
Q3
$201K Hold
5,000
0.06% 329
2022
Q2
$210K Buy
+5,000
New +$210K 0.07% 315
2021
Q3
Sell
-5,000
Closed -$205K 371
2021
Q2
$205K Hold
5,000
0.06% 352
2021
Q1
$218K Hold
5,000
0.08% 294
2020
Q4
$250K Buy
+5,000
New +$250K 0.09% 254